3. ISBN : 1563633752
Author : Medical Economics
Download Here
http://eap-books.club/readonline/?item=1563633752&lan=en
4. Completely revised and updated, the 2001 PDR provides FDA-approved drug information on more
than 4,000 prescription drugs, over 2,100 full-color, actual-size photos of medicines for instant
identification, and important data on over 250 drug manufacturers. New medicines, new drug
interaction data, the most recent side effects findings, and certain drugs now removed from the
market make it absolutely critical that medical and healthcare professionals keep up- to-date with the
very latest prescription drug information. The 2001 PDR contains: the newest drugs-which drugs are
indicated for the diagnosed condition; how different drugs interact; latest findings on side effects
caused by the prescribed drug; recommended dosages; clinical pharmacology; pediatric use;
contraindications; FDA use-in-pregnancy ratings; and more. Hundreds of new drugs added including:
Relenza & Tamiflu, Tequin & Avelox, Synercid I.V., Celebrex, Norvir, Protonix, Elexon and Zyvox.
New larger trim size allows dramatically improved readability. 3,000+ pages. Not only are today's
prescription drugs vital to the patient's well-being, but their effectiveness and safety can impact the
integrity and security of all involved healthcare professionals as well. New in '99 - The new 54th
edition comprises 3,000 pages, is extensively illustrated in full colour, and indexes some 4,000 drugs.
Important data on over 250 drug manufacturers is also presented. In today's fast-moving healthcare
field, it is vital that the physician keeps abreast of: The latest drugs - which drugs are indicated for the
diagnosed condition How different drugs interact Latest findings on side effects caused by the
prescribed drug Recommended dosages Clinical pharmacology Paediatric use Contraindications
FDA use-in-pregnancy ratings And much, much more . The 2000 PDR(R) guarantees the physician
the security and safety of having up- to-the-minute official FDA-approved information on over 4,000
prescription drugs and important data on over 250 drug manufacturers. Among the new drugs
featured in this edition are Xenical, the first of a new class of drugs called lipase inhibitors, indicated
for obesity management including weight loss and weight maintenance when used in conjunction with
a reduced-calorie diet; Avandia, a new member of a class of antidiabetic agents which acts primarily
by increasing insulin sensitivity in muscle and adipose tissue; Celebrex and Vioxx, two new non-
steroidal anti-inflammatory drugs; iEnbrel, a new treatment option for rheumatoid arthritis; Pletal, a
phosphodieterase III inhibitor that reveribly inhibits platelet aggregation; and Agenerase, a new
selective synthetic inhibitor of HIV-protease.Section 1 - Manufacturers' IndexA listing of all
pharmaceutical manufacturers participating in Physicians' Desk Reference(R). All addresses,
telephone numbers, and emergency contacts are given. Section 2 - Brand and Generic Name Index -
This index lists every product alphabetically by both brand and generic name.Section 3 - Product
Category Index - Lists products by prescribing category - allowing quick and easy identification of all
agents with a given therapeutic use or mechanism of action.Section 4 - Product Identification Guide -
Presents full-colour, actual size photographs of tablets and capsules, plus pictures of a variety of
other dosage forms and packages. Section 5 - Product Information - The main section of the book.
Includes entries for over 2,200 pharmaceuticals.
Download Here
http://eap-books.club/readonline/?item=1563633752&lan=en